The Potential Cost-Effectiveness of HIV Vaccines: A Systematic Review (Q28973596)

https://scigraph.springernature.com/pub.10.1007/s41669-016-0009-9

volume

1

0 references

issue

1

0 references

page(s)

1-12

0 references

exact match

0 references

cites work

Pre-exposure prophylaxis for the prevention of HIV infection in high risk populations: a meta-analysis of randomized controlled trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

A brief history of the global effort to develop a preventive HIV vaccine

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The cost and impact of scaling up pre-exposure prophylaxis for HIV prevention: a systematic review of cost-effectiveness modelling studies

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

HALYS and QALYS and DALYS, Oh My: similarities and differences in summary measures of population Health

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

6 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Projected economic evaluation of the national implementation of a hypothetical HIV vaccination program among adolescents in South Africa, 2012.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The Case for Adolescent HIV Vaccination in South Africa: A Cost-Effectiveness Analysis

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Exploring the Potential Health Impact and Cost-Effectiveness of AIDS Vaccine within a Comprehensive HIV/AIDS Response in Low- and Middle-Income Countries

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

PUBLIC HEALTH. Toward an HIV vaccine: A scientific journey

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

How can we get close to zero? The potential contribution of biomedical prevention and the investment framework towards an effective response to HIV.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The contribution of vaccination to global health: past, present and future

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Is a HIV vaccine a viable option and at what price? An economic evaluation of adding HIV vaccination into existing prevention programs in Thailand

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The cost-effectiveness of a modestly effective HIV vaccine in the United States

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Decision support in vaccination policies

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Potential population health outcomes and expenditures of HIV vaccination strategies in the United States

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The impact of an AIDS vaccine in developing countries: a new model and initial results.

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

The economics of HIV vaccines: projecting the impact of HIV vaccination of infants in sub-Saharan Africa

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

An introduction to Markov modelling for economic evaluation

3 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Extended evaluation of the virologic, immunologic, and clinical course of volunteers who acquired HIV-1 infection in a phase III vaccine trial of ALVAC-HIV and AIDSVAX B/E.

3 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

CONSOLIDATED HEALTH ECONOMIC EVALUATION REPORTING STANDARDS (CHEERS) STATEMENT

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

The potential impact of an HIV vaccine with limited protection on HIV incidence in Thailand: a modeling study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

Calculating QALYs, comparing QALY and DALY calculations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

A therapeutic HIV vaccine: how good is good enough?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS41669-016-0009-9

Cost-effectiveness analysis of antiretroviral drug treatment and HIV-1 vaccination in Thailand.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5373805

Minimal modeling approaches to value of information analysis for health research

26 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28367539